Botox injection in throat may help sleep apnea sufferers
NCT ID NCT07399782
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting botulinum toxin (like Botox) into a throat muscle can help people with moderate to severe obstructive sleep apnea. The goal is to reduce breathing pauses during sleep and improve oxygen levels and daytime sleepiness. The trial involves 20 adults aged 18-50 with a healthy weight and no other major health issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of moderate to severe OSA, confirmed by home or laboratory polysomnography. * Age between 18 and 50 years. * BMI in the range of 18.5-30. * Neck circumference ≤ 44 cm (men) and ≤ 42 cm (women). * Absence of signs of upper obstruction Exclusion Criteria: * Skeletal or craniofacial disorders: * Tonsillar hypertrophy 3-4 * Obesity (BMI \> 30 kg/m²) * Elderly (age \> 50 years) * Neuromuscular diseases (e.g., dystrophies, myasthenia gravis) * Chronic use of medications that alter muscle tone. * Excessive alcohol consumption (\> 14 drinks/week) * Chronic obstructive pulmonary disease (COPD) * Congestive heart failure (NYHA III-IV) or decompensated heart disease. * Concomitant sleep disorders: narcolepsy, restless legs syndrome, sleep behavior disorder (REM). * Predominant central or mixed sleep apnea on polysomnography (≥ 50% central events). * Previous airway surgery (uvulopalatopharyngoplasty, recent tonsillectomy). * Pregnancy or postpartum (\< 6 months). * Neurological conditions: Previous stroke, Parkinson's disease, dementia.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sleep apnea syndrome (OSAS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple mouthpiece silence snoring?
- Your phone could flag sleep apnea while you sleep
- Wearable ECG patch could unlock hidden heart risks
- Can a new pressure relief mode outperform standard therapy for sleep apnea?
- Freezing away sleep apnea: a new procedure targets throat fat to open the airway
- Could a tiny nerve implant silence sleep apnea without a mask?